https://www.biospace.com/article/releases/genentech-s-novel-anti-tigit-tiragolumab-granted-fda-breakthrough-therapy-designation-in-combination-with-tecentriq-for-pd-l1-high-non-small-cell-lung-cancer/
Research Projects
August 20, 2020
Research Efforts Abound in HER2-Positive Gastric and GEJ Cancers
Biomarkers play an essential role in the diagnosis and management of patients with gastric and gastroesophageal junction (GEJ) cancers, according […]
May 16, 2018
North Texas Researchers Developing “Trap†To Fight Cancer
Researchers at the University of Texas at Arlington have developed what they are hoping will be a new tool in […]
April 16, 2018
Robotic Implants: Harmonizing Technology and Human Biology
Robotic implants are a promising technological advancement that may pave the way for a safe and reliable method for tissue […]
April 12, 2018
Growth Opportunities of Esophageal Cancer Phase III Drugs market in the Global Industry with analysis, Expected Growth and Forcast By 2023
Esophageal Cancer Phase III Drugs Market – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive […]
April 6, 2018
How The Cancer Genome Atlas Will Shape the Future of Cancer Research
A decadelong effort to genomically characterize multiple cancers begets a huge archive: 33 cancer types, 11,000 tumors and 27 new […]
January 13, 2018
Tiny robots inserted in pigs are making tissue grow inside the body
A Canadian scientist working in the U.S. has constructed robotic implants that can stimulate the growth of tissue inside a […]
December 16, 2017
ctDNA Detection has Immense Potential in Cancer Diagnosis
According to a new research report by RNCOS entitled, “Global Liquid Biopsy Market Outlook 2020â€, innovation and technological advancements based […]
December 8, 2017
Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing Proceeds to Fund Pivotal Trial in Breast Cancer
Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, today provided an update on the company’s development strategy […]
December 7, 2017
UH cancer researcher focused on tumor development
A cancer researcher at the University of Houston is set to deliver an unprecedented look at the 20-year development of […]